Trial Profile
An Open Label, 4 Escalating Dose, Randomized Multicentre Study Evaluating the Safety and Activity of Ferroquine Associated With Artesunate Versus a Positive Calibrator (Amodiaquine Associated With Artesunate) in African Adult Patients With Uncomplicated Malaria
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 25 Sep 2017
Price :
$35
*
At a glance
- Drugs Ferroquine (Primary) ; Amodiaquine; Artesunate
- Indications Malaria
- Focus Adverse reactions
- Sponsors Sanofi
- 01 Aug 2017 Results assessing safety of different doses of ferroquine with artesunate (AS) in adult African patients with uncomplicated malaria, were published in the American Journal of Tropical Medicine and Hygiene.
- 07 Nov 2014 New trial record